Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
Go back to Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 26.40 +0.01 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.39 | 52 Week High | $42.49 | |||
| Open | $26.40 | 52 Week Low | $16.64 | |||
| Day High | $26.40 | P/E | N/A | |||
| Day Low | $26.40 | EPS | $-0.42 | |||
| Volume | 31,304 | |||||
